Key Findings
Masimo’s smartSET has gained FDA 510(k) clearance to detect atrial fibrillation (AFib) and opioid-induced respiratory depression (OIRD) in real time. In clinical validation, the AFib detection feature achieved 100% specificity and 97% sensitivity, using concurrent ECG strips read by three clinicians as the ground truth standard.
Technical Details
The system utilizes photoplethysmography (PPG) and AI-driven pattern recognition. Rather than relying on raw numerical trends, smartSET analyzes data across three parameters: SpO2, pulse rate, and perfusion index. These patterns trigger escalating notifications on the Radius VSM wearable device. It is important to note that the AFib capability is cleared as a supplement for screening in patients 18 and older; it serves as a prompt for further evaluation and does not replace ECG confirmation or provide a final diagnosis.
Background & Context
The technology addresses two silent failure modes in hospital settings that often occur between nursing rounds. AFib affects more than 10% of patients over 65 and frequently remains undetected until a stroke occurs. Regarding OIRD, 85% of postoperative events occur within the first 24 hours after surgery, and one in 10 surgical patients receiving opioids experiences an opioid-related adverse event.
Significance & Outlook
For clinical trial teams conducting postoperative studies, smartSET provides an operationally relevant tool for continuous monitoring in general care floor settings where telemetry is not standard. The technology leverages a massive installed base; Masimo SET is the primary pulse oximetry platform at all 10 top U.S. hospitals in the 2026 Newsweek World’s Best Hospitals ranking and monitors an estimated 200 million patients annually. As post-market data accumulates, the primary metric for evaluation will be how the AFib flagging rate performs across heterogeneous inpatient populations, including those with other arrhythmias.
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime
